Indeed, its ability to prolong the systemic half-life of therapeutic agents and selectively accumulate in tumor tissues contributes to reduced off-target toxicity.60 We thus used EM127 encapsulated within HSA-based nanoparticles for the subsequent in vivo studies. The gene discussed is ALB; the disease is neoplasm.